Introduction {#S1}
============

Non-syndromic oculocutaneous albinism (nsOCA) is an inherited disorder of melanin biosynthesis with an autosomal recessive mode of inheritance. Skin, hair, and eyes in nsOCA patients are either hypopigmented or completely devoid of melanin ([@B27]). The accompanying optic defects include poor visual acuity, photodysphoria, strabismus, nystagmus, foveal hypoplasia, iris transillumination, and abnormal projection of visual fibers ([@B16]).

The nsOCA is genetically heterogeneous with seven loci (OCA1--OCA7) reported to date. Among the seven forms, OCA1 (MIM 203100) is the most common and severe with a prevalence rate of 1 in 40,000 individuals worldwide and is caused by genetic defects in the tyrosinase (*TYR/*OCA1) located on chromosome 11q14--q21 ([Supplementary Table S1](#DS2){ref-type="supplementary-material"}). It codes for tyrosinase enzyme present inside the melanocytes of the skin, hair, and eyes ([@B4]; [@B8]). Tyrosinase is a copper-containing enzyme that catalyzes the first two steps of melanin biosynthesis. OCA1 is further categorized into two subtypes: OCA1A, where patients represent unpigmented hair and skin throughout life due to complete absence of tyrosinase activity, and OCA1B, where some of the enzyme activities are present, causing some melanin accumulation over time ([@B8]; [@B28]).

OCA2 (MIM 203200) caused by *OCA2* (previously called P; 15q11.2--q12) accounts for approximately 30% of the OCA cases worldwide. The encoded protein is a transmembrane protein that mediates a chloride-selective anion conductance required for melanin synthesis ([@B21]; [@B1]; [@B13]). OCA type3 (MIM 203290) is the most common type in black Africans affecting almost 1 in 8,500 individuals ([@B24]). It is caused by defects in *TYRP1* (9p23) that encodes tyrosinase-related protein 1 (TYRP1), which is involved in maintaining the melanosomal structure and affects the melanocyte proliferation and cell death ([@B13]).

OCA4 (MIM 606574) is rarely reported from Asian and European populations with a prevalence rate of 1 in 100,000, but it accounts for 24% of OCA cases in Japan ([@B12]). It is caused by defects in the *SLC45A2* (5p13.3) that encodes a solute carrier family 45 member 2 (SLC45A2) protein, which is present in melanosomal membranes and ensures the elevated pH in the melanosome by functioning as a proton/sugar symporter ([@B2]). The genetic identity of OCA5 locus mapped to chromosome 4q24 is yet to be discovered ([@B14]).

OCA6 (MIM 113750) and OCA7 (MIM 615179) are caused by defects in the solute carrier family 24 member 5 (*SLC24A5*) and *C10orf11*, respectively ([@B7]; [@B34]; [@B20]).

Several studies from Pakistan have reported molecular analysis of the nsOCA ([@B14], [@B15]; [@B25]; [@B9], [@B10]; [@B26]). Among the pathogenic variants detected so far, the *TYR* and *OCA2* are the most common causes of autosomal recessive OCA in the Pakistani population ([@B26]). OCA4 is rarely reported from the Pakistani population, with only four mutations reported to date ([@B15]; [@B25]). In the present study, we have reported three families (A--C) of Pakistani origin segregating nsOCA in an autosomal recessive manner. Affected individuals in all the three families had similar severe phenotypes, but molecular investigation revealed a novel (NM_000372.5: c.826 T \> C; p.Cys276Arg) and recurrent variant (NM_000372.5: c.832C \> T; p.Arg278^∗^) in *TYR* in families A and B, respectively, and a novel insertion variant (NM_016180.5: c.1331_1332insA; p.Asn444LysfsX5) in the *SLC45A2* in family C.

Materials and Methods {#S2}
=====================

Family History {#S2.SS1}
--------------

Three consanguineous families, with autosomal recessive nsOCA, were recruited from Khyber Pakhtunkhwa, Pakistan. Evidence for the autosomal recessive mode of inheritance of the disorder was strongly supported by the pedigree drawings ([Figures 1A--C](#F1){ref-type="fig"}). Affected members were carefully examined, and no additional phenotype other than OCA-related was observed. Blood samples were obtained from all available members including parents and affected and healthy siblings in all three families in EDTA vacutainer sets. The study was approved by the Departmental Review Committee and Ethical Review Committee of Hazara University, Mansehra, Pakistan. Written informed consent for collection of blood samples and publication of clinical and research data in peer-reviewed journals was obtained from all those who participated in the study.

![Panels **(A--C)** show pedigree drawings of the three families (A--C) segregating the disorder in an autosomal recessive manner. Individuals marked with asterisks (\*) indicate the samples available for the study. In family C, the haplotype of microsatellite markers is shown below the symbols. Panels **(D--F)** represent photographs of affected members of the three families showing white milky skin and completely unpigmented hair, eyebrows, and eyelashes. **(G,H)** Upper panels represent the nucleotide sequence of a novel (c.826T \> C) and a recurrent (c.832C \> T) mutation identified in exon 2 of the *TYR* in families A and B, respectively. The middle and lower panels represent the nucleotide sequence in the heterozygous carriers and unaffected healthy individuals, respectively. **(I)** Upper panel represents nucleotide sequence (c.1331_1332insA) identified in the *SLC45A2* in family C. Middle panel shows the sequence in heterozygous carrier and the lower panel in healthy individual. Above the nucleotides in panels **(H,I)** represents the stop codon generated due to mutations.](fgene-11-00749-g001){#F1}

DNA Extraction and Molecular Investigation {#S2.SS2}
------------------------------------------

Genomic DNA was extracted using DNA purification kit (Thermo Fisher Scientific, Lithuania) following the manufacturer's guidelines. To assess the quality of extracted DNA, it was analyzed on 1% agarose gel followed by staining with ethidium bromide.

Based on the clinical findings recorded in affected members, the *TYR* (ENSG00000077498) was sequenced in all three families. Primers, to polymerase chain reaction (PCR)-amplify exons and splice junction sites of the gene, were designed using the Primer3 software. Primer sequences, melting temperature (Tm), and amplicon sizes are available on request. Initially, one affected member from each family was selected for sequencing *TYR*. PCR reaction was carried out in 50 μl volume containing 50 ng genomic DNA, 20 μl ready reaction mastermix, and 10 pmoles forward and reverse primers. The thermocycling conditions used included initial denaturation at 95°C for 5 min followed by 35 cycles at 94°C for 1 min, 57--59°C for 1 min, 72°C for 45 s, and final extension at 72°C for 10 min.

The amplified PCR products were analyzed on 2% agarose gel. Later, these were purified by commercially available kits (MBI Fermentas, Life Sciences, United Kingdom) prior to subjecting to sequencing. Analysis of the sequenced data was performed *via* BIOEDIT 7.0.9^[1](#footnote1){ref-type="fn"}^.

In family C, after failing to detect any disease-causing variant in the *TYR*, homozygosity mapping was performed by typing microsatellite markers flanking genes causing other types of nsOCA. Physical and genetic distances of the markers were obtained from Rutger's map built 36.2 ([@B19]). For PCR, markers were amplified using the standard conditions ([@B32]) and resolved by electrophoresis on 8% non-denaturing polyacrylamide gel (PAGE). The *SLC45A2* (ENSG00000164175) was then sequenced by using the same conditions as described above.

Segregation of the identified mutations with the disorder within the families was carried out by sequencing the rest of the available affected and unaffected members. Polymorphism of the mutations identified in *TYR* and *SLC45A2* was excluded by searching their presence in various databases and screening 100 healthy, ethnically matched control individuals.

*In silico* Analysis and Structural Predictions {#S2.SS3}
-----------------------------------------------

Structural and functional influence of the identified variants was carried out through Polyphen^[2](#footnote2){ref-type="fn"}^, SIFT^[3](#footnote3){ref-type="fn"}^ and I-MUTANT 3.0 server^[4](#footnote4){ref-type="fn"}^, PROVEAN-Protein Variation Effect Analyzer^[5](#footnote5){ref-type="fn"}^, PhD-SNP-Predictor of human Deleterious Single Nucleotide Polymorphisms^[6](#footnote6){ref-type="fn"}^ and SNPs&GO^[7](#footnote7){ref-type="fn"}^, and Mutation Taster^[8](#footnote8){ref-type="fn"}^.

Secondary structure details were retrieved through PDBsum^[9](#footnote9){ref-type="fn"}^, and full-length three-dimensional (3D) structures of human TYR and SLC45A2 proteins were constructed through homology modeling approach^[10](#footnote10){ref-type="fn"}^ using Swiss model^[11](#footnote11){ref-type="fn"}^ and ITasser server ([@B35]) using 5M8Q (44.4% identity) and 4M64 (87% identity) as template for TRY and SLC45A2, respectively. Stereochemistry and validity of the constructed 3D protein structures were assessed by Ramachandran plots ([@B17]), ProQ ([@B23]), and Verify3D ([@B6]), and the coarse packing quality was evaluated with WHAT IF ([@B33]). To enhance the model quality for further analysis, energy minimization and structure refinements were made using GROMMACS available in Chimera 1.5.6 ([@B22]) and VEGA ZZ^[12](#footnote12){ref-type="fn"}^.

*In silico* Site-Directed Mutagenesis and Root-Mean-Square Deviation Calculation {#S2.SS4}
--------------------------------------------------------------------------------

The 3D structure of the mutant (TYR^C276R^) was constructed using wild-type protein (TYR^WT^) as a template. The mutant model was evaluated for its stereo chemical quality and environmental profile using PROCHECK ([@B18]) and ERRAT (Structure analysis and verification servers), respectively. To minimize the potential energy and to calculate root-mean-square deviation (RMSD) of native and mutant structures, NOMAD-Ref^[13](#footnote13){ref-type="fn"}^ and Chimera 1.5.6 tools were used ([@B22]).

Hydropathy and Topology Analysis {#S2.SS5}
--------------------------------

To evaluate and differentiate the transmembrane (TM) helices of normal and mutated proteins, Membrane Protein Explorer (MPEx) was used to analyze the hydrophobicity of the respective amino acids ([@B30]; [@B29]). The MPEx tool predicts the TM region by using experimental values of hydrophobicity scales based on biological and physical analyses. Effect of particular mutation on TM helices is usually evaluated through this tool. Additionally, TransMembrane protein Re-Presentation in 2 Dimensions (TMRPres2D) tool was used for 2D visualization of TM segments. Next, to investigate the arrangement of protein secondary structure to form pores and channels for passage of ions, CAVER analyte 2.0 was used ([@B3]).

Molecular Dynamic Simulations {#S2.SS6}
-----------------------------

Molecular dynamic (MD) simulation studies of TYR^WT^ and TYR^C276R^ were made to assess the folding, stability, conformational changes, and dynamic behaviors of TYR. Amber03 force field embedded in GROMACS 4.5 package running on high-performance OpenSuse linux system was used to perform simulations ([@B5]). Throughout the simulation experiments, both TYR^WT^ and TYR^C276R^ systems were solvated by TIP4P water model in a periodic box ([@B36]). The system was neutralized by addition of Na^+^ and Cl^--^ counter ions. Energy minimization (steepest descent algorithm for 500 steps) was executed by tolerance of 1,000 kJ/mol Å^2^ to eliminate initial steric clashes. After completing the minimization steps, systems were subjected to simulations for 30 ns timescale under constant temperature (300 K) and pressure (1 atm). To this end, electrostatic interactions were calculated using Particle Mesh Ewald (PME) algorithm. To investigate the stability behavior of TYR^WT^ and TYR^C276R^ systems, VMD ([@B11]), PyMol^[14](#footnote14){ref-type="fn"}^, and GROMACS tools were used.

Results {#S3}
=======

Clinical Description {#S3.SS1}
--------------------

Family A: three affected individuals (IV-1, IV-3, IV-4) in this family were aged 7--18 years at the time of the study. White milky skin, white hair, white eyebrows, and white eyelashes, indicating complete absence of pigment, were observed in all three affected members ([Figure 1D](#F1){ref-type="fig"}). In two of the affected individuals (IV-1, IV-3), ophthalmic features including photophobia, nystagmus, and strabismus were recorded. However, iris color was gray/blue in all three individuals.

Family B: at the time of the study, affected members IV-1 and IV-3 were 13 and 3 years old, respectively. Both presented white skin, white hair, white eyebrows, and white eyelashes ([Figure 1E](#F1){ref-type="fig"}). Elder affected sister (IV-1) had photophobia, nystagmus, and strabismus. Her eyesight was extremely weak, and she sits near a teaching board in the classroom. The strabismus was the only observable feature in the younger affected sister (IV-3). However, both of them had gray/blue iris color.

Family C: at time of the study, affected members IV-3 and IV-4 were 24 and 26 years of age, respectively. Both had white milky skin and depigmented hair, eyebrows, and eyelashes ([Figure 1F](#F1){ref-type="fig"}). The ophthalmic features including nystagmus, strabismus, photophobia, and blue iris color were observed in both affected members. Eyesight was weak, and they were unable to see without glasses.

Unaffected individuals in all three families exhibited normal pigmentation of skin, hair, and eyes.

Molecular Analysis {#S3.SS2}
------------------

Sequence analysis of *TYR* revealed a novel mutation \[c.826T \> C, p.(Cys276Arg)\] and a previously reported mutation \[c.832C \> T, p.(Arg278^∗^)\] in affected members in families A and B, respectively. Both the mutations were present in homozygous state in all the affected members of two families ([Figures 1G,H](#F1){ref-type="fig"}). In family C, after establishing the linkage at OCA4 on chromosome 5p13.3 ([Figure 1C](#F1){ref-type="fig"}), sequence analysis of the candidate gene *SLC45A2* revealed a novel homozygous insertion mutation (c.1331_1332insA) in affected members ([Figure 1I](#F1){ref-type="fig"}). The mutation led to a frameshift and premature termination codon 9 bp downstream in the same exon (p.Asn444LysfsX5). Various bioinformatics tools including SIFT, POLYPHEN, I-MUTANT, PROVEAN, PhD-SNP, SNPs&GO, and Mutation Taster predicted that the mutations, p.(Cys276Arg) and p.(Asn444LysfsX5), carry a damaging effect on structure and function of the TYR and SLC45A2 protein ([Table 1](#T1){ref-type="table"}).

###### 

*In silico* Analysis of Mutations in *TYR* and *SLC45A2*.

                           **Polyphen**       **Sift**      **I mutant**   **PROVEAN**   **PHD-SNP**   **SNPs&GO**   **Mutation taster**   
  ------------------------ ------------------ ------------- -------------- ------------- ------------- ------------- --------------------- --------------------
  TRY^Cys276Arg^           Score              1             0.00           RI = 6        −9.11         4             RI = 8                180
                           Predicted effect   Deleterious   Damaging       Disease       Deleterious   Disease       Disease               Altered protein
                                                                                                                                           
  SLC45A2^Asn444LysfsX5^   Score              0.7           0.05           RI = 4        −6.01         2             RI = 6                94
                           Predicted effect   Deleterious   Damaging       Disease       Deleterious   Disease       Disease               Splice site change

RI, reliability index.

Unaffected healthy individuals in all three families were heterozygous for the identified mutations. None of the mutations was detected in 100 ethnically matched, unrelated, and healthy control individuals. Also, the identified mutations had negligible frequencies, if any, when searched in gnomAd in the general population^[15](#footnote15){ref-type="fn"}^ ([Table 2](#T2){ref-type="table"}).

###### 

Clinical and molecular investigation of affected individuals with mutations in *TYR* and *SLC45A2*.

  **Gene**                     ***TYR***       ***SLC45A2***                                                                          
  ---------------------------- --------------- ------------------------ ------------------- ------------- ------------- ------------- -------------
  Inheritance                  AR              AR                       AR                                                            
  Nucleotide change            c.826T \> C     c.832C \> T              c.1331_1332insA                                               
  Amino acid change            p.(Cys276Arg)   p.(Arg278\*)             p.(Asn444LysfsX5)                                             
  AllelicFrequency \* Wt/Mut   826T/C (0)      832C (0.999)/T (0.001)   1331A/AA (0)                                                  
  Affected members             IV-1            IV-3                     IV-4                IV-1          IV-3          IV-3          IV-4
  Gender                       M               F                        F                   F             F             M             M
  Age in years                 15              13                       7                   13            3             24            26
  Hair color                   White           White                    White               White         White         White         White
  Eyebrows/eyelashes           White           White                    White               White         White         White         White
  Skin color                   Milky white     Milky white              Milky white         Milky white   Milky white   Milky white   Milky white
  Iris color                   Gray/blue       Gray/blue                Gray/blue           Gray/blue     Gray/blue     Gray/blue     Gray/blue
  Photophobia                  \+              \+                       −                   \+            −             \+            \+
  Nystagmus                    \+              \+                       −                   \+            −             \+            \+
  Strabismus                   \+              \+                       −                   \+            \+            \+            \+
  Eyesight                     Weak            Weak                     NA                  Weak          NA            Weak          Weak

AR, autosomal recessive; Wt, wild type; Mut, mutant; M, male; NA, not available; + indicates the presence of a phenotypic character; − indicates the absence of a phenotypic character; \* indicates frequencies of the variants, if any, found in gnomAd in the general population (

https://gnomad.broadinstitute.org/

).

Secondary and Tertiary Structure of TYR and SLC45A2 {#S3.SS3}
---------------------------------------------------

The 2D structure analysis of TYR showed 18 alpha helices, 12 beta sheets, 7 disulfide bridges and four beta hairpins ([Figures 2A,B](#F2){ref-type="fig"}). The novel p.(Cys276Arg) mutation identified in family A resulted in a loss of disulfide bridge ([Figure 2C](#F2){ref-type="fig"}). Due to unavailability of the full-length TYR structure, homology modeling and protein threading techniques were used to model the TYR^WT^. The TYR^WT^ structure was used to model TYR^C276R^ that mapped Cys276Arg mutation in the cysteine-rich motif 2 (residues 244--322) of catalytic domain of TYR ([Figure 3A](#F3){ref-type="fig"}). Normal and mutant TYR protein models were superimposed to find the model fluctuation. Both models were very well superimposed except the mutant residue ([Figure 3B](#F3){ref-type="fig"}). The predicted models of TYR^WT^ and TYR^C276R^ were used to calculate the bond angles of amino acid coordinated using Ramachandran plot, which indicated approximately 97.37% residues in the allowed region. Furthermore, additional factors comprising of non-bonded interactions, peptide bond planarity, main chain H-bond energy, poor rotamers, overall G-factor, and Ca tetrahedral distortion for the modeled structures were mapped in the favorable range ([Figures 3C,D](#F3){ref-type="fig"}).

![Comparative 2D structure and topology analysis of TYR^WT^ and TYR^C276R^. **(A)** Secondary structure of TYR^WT^, disulfide bridges are shown in yellow line, and β-hairpin structure is indicated by a red loop. **(B)** Close-up view of cysteine bridge of TYR^WT^ and **(C)** loss of cysteine bridge in TYR^C276R^.](fgene-11-00749-g002){#F2}

![Structure validation and motif organization of human TYR protein. **(A)** Crystal structure of TYR is shown in ribbon model with its respective color depicting critical function. For each subunit, the different domains/motifs are identified on ribbon models and their respective function is indicated. **(B)** Ramachandran plot of TYR^WT^. **(C)** Superimposed model of TYR^WT^ (deep pink) and TYR^C276R^ (blue) while the wild type and mutant residues are shown in ball and stick model. **(D)** Ramachandran plot of TYR^C276R^.](fgene-11-00749-g003){#F3}

Secondary structure of SLC45A2 showed 11alpha helices ([Figure 4A](#F4){ref-type="fig"}). Tertiary protein model of SCL45A2 was also constructed through homology modeling and threading approaches ([Figure 4B](#F4){ref-type="fig"}). The resulting model was checked for stereochemistry and geometry optimization. Ramachandran plot indicated 98% residues in the favorable region with a z-score of −2.38 ([Figure 4C](#F4){ref-type="fig"}). The RMSD between TYR^WT^ and TYR^C276R^ was 0.149, while the RMSD between SLC45A2^WT^ and SLC45A2^Asn444LysfsX5^ was 0.183, respectively.

![Protein modeling and its validation. **(A,B)** Secondary structure and tertiary protein model of SLC45A2. **(C)** Ramachandran plot of normal SLC45A2.](fgene-11-00749-g004){#F4}

Assessment of Conservation Pattern of Cys276 in TYR {#S3.SS4}
---------------------------------------------------

The functionally important amino acids are highly conserved. Therefore, to cross validate the evolutionary significance of a novel mutation p.(Cys276Arg) in the human TYR protein, multiple-species sequence alignment was performed using ClustalW with seven homologs. Results showed conservation of the cysteine at amino acid position 276 in the cysteine-rich motif 2 of TYR ([Supplementary Figure S1A](#DS1){ref-type="supplementary-material"}). Additionally, the change from polar uncharged amino acid to basic amino acid was clearly evident in 2D and 3D conformations ([Supplementary Figures S1B,C](#DS1){ref-type="supplementary-material"}).

Hydropathy and Topology Plot Analysis {#S3.SS5}
-------------------------------------

To gauge the functional influence of p. (Cys276Arg) mutation in TYR, initially, we mapped and characterized its structural placement. Hydropathy results showed that the N-terminal part of the protein lies toward the extracellular part of the membrane, and the C-terminal part of TYR has TM helices. Hydropathy plot ([Figure 5A](#F5){ref-type="fig"}) analysis showed that Cys276Arg substitution is significant for the structure of protein. Membrane protein functioning depends on its topology confirmation. The topology showed that the signal peptide at the N-terminus was extracellular and C-terminal region was intracellular. Overall, the topology was the same in wild-type and mutant TYR with minor shifting ([Figure 5B](#F5){ref-type="fig"}). Protein tunnels help in connecting the functional buried cavities with bulk solvent and protein channels and facilitate the movement of ions and second messengers across the membrane.Interestingly, the Cys276Arg was observed in tunnel formation ([Figure 5C](#F5){ref-type="fig"}), and Cys to Arg substitution within the tunnel might decrease the stability and activity of the TYR protein. Overall, pore length was 72.259 with a score of 0.844. Bottle neck of pore was 1.587 and straightness 0.849.

![Hydropathy and topology analysis of TYR^WT^ and TYR^C276R^. **(A)** Hydropathy plot of normal and mutated TYR amino acids performed by the Membrane Protein Explorer (MPEx) tool. **(B)** Topology plot of TYR. Signal peptide is shown in red balls, while C276 residue is highlighted by a red arrow. **(C)** Tunnel in TYR protein shown in hydrophobic model and the rest of the protein in wire model. In hydrophobic model residues are colored according to their physiochemical properties.](fgene-11-00749-g005){#F5}

Next, the topology analysis of SLC45A2 showed 12 TM domains of native protein while the last two TM domains were deleted due to frameshift and premature stop codon in the mutant SLC45A2 protein ([Supplementary Figure S2](#DS1){ref-type="supplementary-material"}).

Molecular Dynamics Simulation Analysis {#S3.SS6}
--------------------------------------

The TYR^WT^ and TYR^C276R^ were further analyzed by MD simulation assay in order to study the time-dependent behavior and to investigate the overall stability of the system. Atom trajectories were used to plot the root mean square fluctuation (RMSF) to measure the secondary structural elements' stability and conformational deviations. In TYR^WT^, the high fluctuation was observed between 200 and 300 residues, and the system remained stable throughout the protein length. To our surprise, a region encompassing Cys276Arg indicated more fluctuations up to 5A° ([Figure 6A](#F6){ref-type="fig"}). Fluctuation in this particular region was due to disulfide bridging of cysteine residues with arginine with different topologies. These data indicated less tight packaging of TYR^C276R^ as compared to TYR^WT^ ([Figure 6B](#F6){ref-type="fig"}). The stability of secondary structure elements and conformational changes of TYR^WT^ and TYR^C276R^ systems were calculated by plotting the radius of gyration (Rg) obtained throughout the simulated trajectories. The Rg plot is the measure of stability and firmness of the system; the calculated Rg plot ([Figure 6C](#F6){ref-type="fig"}) showed stability except a slight change at 4--5 ns depicting conformational changes upon unfolding.

![Plots to investigate the stability and fluctuation of molecular dynamic (MD) trajectories for a wild-type and mutant TYR. **(A)** Root mean square fluctuation (RMSF) plots computed through each system trajectory **(B)** Three-dimensional (3D) fluctuation of all trajectories on 30 ns timescale. **(C)** Radius of gyration (Rg) plot, TYR^WT^ (blue) and TYR^C276R^ (orange).](fgene-11-00749-g006){#F6}

Discussion {#S4}
==========

In the present study, we have clinically and genetically investigated three consanguineous families (A, B, C) demonstrating the autosomal recessive form of nsOCA. Affected individuals in all three families presented similar cutaneous and ophthalmic features ([Table 2](#T2){ref-type="table"}). Sequence analysis of the candidate genes revealed three disease-causing variants. This included a novel missense p.(Cys276Arg) and a previously reported nonsense mutation p.(Arg278^∗^) in the *TYR* in families A and B, respectively, and a novel frameshift mutation p.(Asn444LysfsX5) in the *SLC45A2* in family C.

A novel missense mutation p.(Cys276Arg) in the *TYR*, identified in family A, involved substitution of a cysteine with arginine at amino acid position 276. Cysteine is one of the polar uncharged amino acids, which stabilizes the protein 3D structure through formation of a disulfide bridge. Human tyrosinase contains 17 cysteine residues distributed among two cysteine-rich motifs. Ten of these residues are located in the cysteine-rich motif I (20--151 residues) and the other five in the cysteine-rich motif II (244--322) ([@B28]). The substituted cysteine in p.(Cys276Arg) is present in motif II. Through *in silico* deep structural analysis, we have elucidated the structural and functional behavior of TYR upon cysteine substitution in motif II. In addition, homology modeling and threading-based approaches predicted the model structure of native and mutant TYR. The results showed substitution of Cys276 with Arg resulted in a loss of a disulfide bridge that existed between Cys35 and Cys276, which altered the conformation and configuration of the protein, leading to reduced protein stability. Hydropathy and topology analysis revealed that the mutation p.(Cys276Arg) is significantly pushing the helical region of the protein toward the intramembrane side. MD simulation analysis revealed that this mutation caused an alteration in protein structural behavior. In addition, fluctuations were observed in the loop region encompassing the mutation, and this alteration might play a role in inducing albinism in family A. The recurrent c.832C \> T mutation in family B introduces the premature stop codon p.(Arg278^∗^) leading to TYR inactivation that lacks the second copper-binding domain.

*SLC45A2* was reported for the first time in Turkish OCA patients ([@B31]). It has seven exons that encode the SLC45A2 protein also called membrane-associated transport protein (MATP), with 12 putative transmembrane domains. SLC45A2 is specifically expressed in melanosomes and endosomes. It functions as a sugar transporter by utilizing the proton gradient and maintains the melanosomal pH that is essential for copper ion coordination into the TYR. Small interfering RNA (siRNA)-mediated knockdown of SLC45A2 resulted in acidification of melanosomes that in turn reduced the l-3,4-dihydroxyphenylalanine (L-DOPA) oxidase activity of TYR and melanin content ([@B2]).

Mutations in *SLC45A2* are infrequently reported from Asian, European, African, and North Americans. Of the 95 mutations reported so far in *SLC45A2* ([Supplementary Table S2](#DS2){ref-type="supplementary-material"}), only four, including three novel and one recurrent mutation, have been reported from Pakistan ([@B15]; [@B25]). In this study, we have reported the fourth novel mutation (c.1331_1332insA) in the *SLC45A2* from Pakistan. The c.1331_1332insA mutation results in premature termination, leading to loss of the last two TM domains in the SLC45A2 protein. As our patients show the complete loss of pigmentation that is unusually reported for OCA4 phenotypes, so we could speculate that the truncated protein generated will most probably be destroyed by nonsense mediated decay (NMD). This may have affected the melanosomal activities to such an extent that even minimal melanin has not been synthesized.

Conclusion {#S5}
==========

Conclusively, molecular and *in silico* analyses of identified mutations in TYR and SLC45A2 protein provide the pathogenicity prediction as well as structural and functional changes that are likely to confirm the contribution to pathogenesis of albinism. The present computational analysis provides a theoretical basis for the molecular mechanism of albinism underlying *TYR* and *SLC45A2* gene mutations. Our study expanded the mutation spectrum in the *TYR* and *SLC45A2* and emphasizes that molecular investigations are essential for accurate disease diagnosis. Overall, this study will contribute to further studies of disease prevention and treatment of TYR- and SLC45A2-related albinism.
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